flu vaccine news from FierceVaccines
NewsNovartis opens non-profit R&D vaccine center
One of the world's biggest pharma companies is breaking its business mold for its new R&D center for vaccines. Novartis is modeling its new vaccine development center in Italy on the Novartis Read more...
Novartis to offer data on pre-pandemic jabs
Novartis hasn't given up in its pursuit of profits. The Swiss company has been making an argument for use of its experimental flu vaccine ahead of any potential outbreak. Vaccines chief Jörg Read more...
Flu jab missing the mark in seasonal campaign
There's growing evidence around the U.S. that the flu jab offers only marginal protection against the seasonal ailment. In Texas, doctors say this year's flu vaccine guarded against less than 30 Read more...
Universal flu vaccine shows early promise
Acambis has stirred a significant amount of buzz with some early-stage human data demonstrating the effectiveness of its Read more...
| Press ReleasesAcambis reports positive data from trials of universal influenza A vaccine Acambis reports positive data from trials of universal influenza A vaccine Cambridge, UK and Cambridge, Massachusetts – 3 January 2008 – Acambis plc (Acambis) (LSE: ACM), a leading vaccine Read more... PRESS RELEASE: VaxInnate Initiates Phase I Clinical Study of M2e Universal Influenza Vaccine VaxInnate Initiates Phase I Clinical Study of M2e Universal Influenza Vaccine Company’s First Clinical Trial Studies Vaccine Based on New Vaccine Technology Cranbury, NJ, September 25, 2007 – Read more... PRESS RELEASE: Sanofi Pasteur Initiates Phase II Trial of Cell Culture-Based Seasonal Influenza Vaccine Sanofi Pasteur Initiates Phase II Trial of Cell Culture-Based Seasonal Influenza Vaccine SWIFTWATER, Pa., and LYON, France, Nov. 7 -- Sanofi Pasteur, the vaccines division of sanofi-aventis Group, Read more... |
Get more flu vaccine coverage at:
Paid Research Reports
- Pipeline Insight: Nosocomial Vaccines - Minefield or Goldmine?
- Drug Approval Trends at the FDA and EMEA: Process improvements, heightened scrutiny and industry response
- Biotech 2008 – life sciences industry report (online & print)
- Is there a market for alcoholism pharmacotherapies?
- New report provides Rheumatoid Arthritis market insight